Enterprise Plenary Session III

Talks

Coffee Break

Done
Flash Session III (B)
Andreia Magalhães
Done
Oral Session I A
Cristiana Mateus
Done
Poster Session I (w/ Refreshment Break)

Done
Oral Session II C
Gabriela Martins
Done
Flash Session III (C)
Tiago Moreira Gomes
Done
Flash Session I (B)
Clara B. Martins
Done
Flash Session II (C)
Ana F. Pereira
Done
Enterprise Plenary Session I
Josué Carvalho (Ph.D.)
Done
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEP
Done

15/02/2023, 09:40 - 15/02/2023, 10:40 (UTC) (1 hour)

Sofia Venceslau (Ph.D.) Project Manager at GenIbet Biopharmaceuticals sofia.venceslau@genibet.com

GenIbet Biopharmaceuticals is a company whose mission is to manufacture safe and reliable breakthrough products to support worldwide customers on building the therapies of the future. With a team of more than 50 highly qualified professionals, GenIbet supports its customers on the development and manufacturing of unique novel modalities covering a wide range of technologies.
Sofia Venceslau obtained her Ph.D. degree from the NOVA University of Lisbon, Institute of Chemical and Biological Technology (Oeiras, Portugal) in 2011 and is currently a Project Manager in GenIbet Biopharmaceuticals and will be the third confirmed enterprise speaker for the HSR Congress 2023 on February 15th, 2023.